CCAP Stock Analysis
CC
Avoid
Based on Eyestock quantitative analysis, CCAP`s fundamental data and valuation indicate an investment grade of Avoid at the current time.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
Low score
Upside
To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.
Undervalued
Market cap $B
0.703
Dividend yield
10.88 %
Shares outstanding
37.062 B
Website
https://www.crescentbdc.com/Crescent Capital BDC, Inc. is a business development company, which is focused on originating and investing in the debt of private middle market companies principally located in the United States. The company is headquartered in Los Angeles, California and currently employs 200 full-time employees. The company went IPO on 2020-02-03. The firm seeks to maximize the total return of its stockholders in the form of current income and capital appreciation by providing capital solutions to middle-market companies with sound business fundamentals and growth prospects. The firm is focused on investing in marketable and privately originated debt securities, including senior bank loans, high-yield bonds, as well as private senior, unitranche and junior debt securities. The company has a portfolio of approximately 129 companies. The company invests in various industries, including health care equipment and services; software and services; commercial and professional services; consumer services; pharmaceuticals, biotechnology and life sciences; insurance; and 12 other industries. The firm is externally managed by Crescent Cap Advisors, LLC.